Interleukin-17 inhibition in psoriatic arthritis

Lancet. 2015 Sep 19;386(9999):1114-6. doi: 10.1016/S0140-6736(15)61170-9. Epub 2015 Jun 28.

Authors

Philip Helliwell¹, Laura Coates²

Affiliations

¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK. Electronic address: p.helliwell@leeds.ac.uk.
² Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds LS7 4SA, UK.

PMID: 26135705
DOI: 10.1016/S0140-6736(15)61170-9

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Antirheumatic Agents / therapeutic use*
Arthritis, Psoriatic / drug therapy*
Female
Humans
Male

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antirheumatic Agents
secukinumab